FDA Approved: SYMTUZA — Original Application (Janssen Products LP)

View source ↗

Summary

FDA approved Symtuza, a fixed-dose single-tablet regimen containing darunavir, cobicistat, emtricitabine, and tenofovir alafenamide for HIV-1 infection. It is i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Cobicistat (cobicistat)
• Darunavir (darunavir)
• Emtricitabine (Emtricitabine)
• Symtuza (darunavir/cobicistat/emtricitabine/tenofovir alafenamide)
• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

ORIG AP for SYMTUZA (DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE)